| Literature DB >> 7370164 |
Abstract
Administration of C. parvum alone did not improve the survival of C57BL/6 mice injected with the EL4 lymphoma. The anti-tumour effect of anti-EL4 Ig was however increased by C. parvum treatment, and the combination therapy of anti-EL4 Ig and cytotoxic drugs was even more improved. However, C. parvum only had this effect when given by the same i.p. route as the tumour cells, and the effect was greater when C. parvum was injected 5 days before than 1 day after tumour cells.Entities:
Mesh：
Substances：
Year: 1980 PMID： 7370164 PMCID： PMC2010188 DOI： 10.1038/bjc.1980.36
Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640